New infection with heterotypic hepatitis C virus in a patient with long-term hepatitis C virus eradication

Dig Liver Dis. 2001 Oct;33(7):591-4. doi: 10.1016/s1590-8658(01)80113-4.

Abstract

Background: Experimental hepatitis C virus infection in chimpanzees has shown that natural hepatitis C virus infection does not induce protective immunity and reinfection can occur in seroconverted animals.

Aim: To study the clinical, virological and histological outcome of a new infection sustained by a different hepatitis C virus strain after a primary infection with eradication of the original virus.

Patients and methods: A young Italian man with chronic hepatitis C virus type 4 hepatitis was treated with Interferon therapy and achieved a sustained biochemical and virological response. After long follow-up, an asymptomatic flare-up of alanine transaminase occurred. This alanine transaminase increase was associated with serum hepatitis C virus RNA positivity and a low viral load, and the infecting hepatitis C virus genotype was type 3. The clinical and virological course of this new infection is described.

Results and conclusions: This report shows that there is no protective immunity against hepatitis C virus type 3 after infection by hepatitis C virus type 4 strain.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Alanine Transaminase / analysis
  • Antiviral Agents / therapeutic use
  • Biopsy
  • Hepacivirus / classification
  • Hepacivirus / genetics
  • Hepacivirus / immunology*
  • Hepatitis C, Chronic / immunology
  • Hepatitis C, Chronic / therapy
  • Hepatitis C, Chronic / virology*
  • Humans
  • Interferons / therapeutic use
  • Male
  • Polymerase Chain Reaction
  • RNA, Viral / analysis

Substances

  • Antiviral Agents
  • RNA, Viral
  • Interferons
  • Alanine Transaminase